Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1. Crinetics granted 74,000 stock options and 48,850 RSUs to new employees. 2. Equity awards aim to attract talent under the 2021 Inducement Plan. 3. Stock options priced at $33.08, equal to market closing price. 4. Awards vest over four years, contingent on continued employment. 5. Crinetics develops innovative therapeutics for endocrine diseases and tumors.